140 related articles for article (PubMed ID: 32326278)
1. Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) Recipients.
Ye X; Cabral de Rezende W; Iwuchukwu OP; Avadhanula V; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32326278
[No Abstract] [Full Text] [Related]
2. Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients.
Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Henke DM; Patel KD; Piedra FA; Angelo LS; Shah DP; Chemaly RF; Piedra PA
Viruses; 2021 May; 13(6):. PubMed ID: 34073490
[TBL] [Abstract][Full Text] [Related]
3. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.
Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
Front Immunol; 2019; 10():706. PubMed ID: 30984206
[No Abstract] [Full Text] [Related]
4. Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.
Fuentes S; Hahn M; Chilcote K; Chemaly RF; Shah DP; Ye X; Avadhanula V; Piedra PA; Golding H; Khurana S
J Infect Dis; 2020 Feb; 221(4):636-646. PubMed ID: 31745552
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses of healthy adults to the p27 peptide of respiratory syncytial virus fusion protein.
Blunck BN; Aideyan L; Ye X; Avadhanula V; Ferlic-Stark L; Zechiedrich L; Gilbert BE; Piedra PA
Vaccine; 2022 Jan; 40(3):536-543. PubMed ID: 34903371
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients.
Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
J Infect Dis; 2018 Mar; 217(8):1247-1256. PubMed ID: 29365155
[TBL] [Abstract][Full Text] [Related]
7. The Efficiency of p27 Cleavage during
Rezende W; Ye X; Angelo LS; Carisey AF; Avadhanula V; Piedra PA
J Virol; 2023 May; 97(5):e0025423. PubMed ID: 37133390
[TBL] [Abstract][Full Text] [Related]
8. Infection with novel respiratory syncytial virus genotype Ontario (ON1) in adult hematopoietic cell transplant recipients, Texas, 2011-2013.
Avadhanula V; Chemaly RF; Shah DP; Ghantoji SS; Azzi JM; Aideyan LO; Mei M; Piedra PA
J Infect Dis; 2015 Feb; 211(4):582-9. PubMed ID: 25156562
[TBL] [Abstract][Full Text] [Related]
9. Detection of IgA and IgG but not IgE antibody to respiratory syncytial virus in nasal washes and sera from infants with wheezing.
De Alarcon A; Walsh EE; Carper HT; La Russa JB; Evans BA; Rakes GP; Platts-Mills TA; Heymann PW
J Pediatr; 2001 Mar; 138(3):311-7. PubMed ID: 11241035
[TBL] [Abstract][Full Text] [Related]
10. Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells.
Cortjens B; Yasuda E; Yu X; Wagner K; Claassen YB; Bakker AQ; van Woensel JBM; Beaumont T
J Virol; 2017 May; 91(10):. PubMed ID: 28275185
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes.
Waghmare A; Campbell AP; Xie H; Seo S; Kuypers J; Leisenring W; Jerome KR; Englund JA; Boeckh M
Clin Infect Dis; 2013 Dec; 57(12):1731-41. PubMed ID: 24065324
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
[TBL] [Abstract][Full Text] [Related]
13. Development of human antibodies against linear antigenic and immunogenic regions of respiratory syncytial virus (RSV) nucleocapsid and phospho-proteins shows the site-directed characteristics.
Leonova IV; Leonov SV; Waris M; Russi JC; Grandien M; Norrby E
J Clin Virol; 1998 Aug; 11(2):137-47. PubMed ID: 9785215
[TBL] [Abstract][Full Text] [Related]
14. Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins.
Fuentes S; Coyle EM; Beeler J; Golding H; Khurana S
PLoS Pathog; 2016 Apr; 12(4):e1005554. PubMed ID: 27100289
[TBL] [Abstract][Full Text] [Related]
15. Class-specific antibodies to bovine respiratory syncytial virus in experimentally infected lambs.
Sharma R; Woldehiwet Z
Epidemiol Infect; 1992 Feb; 108(1):135-45. PubMed ID: 1547834
[TBL] [Abstract][Full Text] [Related]
16. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
McGinnes Cullen L; Schmidt MR; Morrison TG
J Virol; 2019 May; 93(9):. PubMed ID: 30760576
[TBL] [Abstract][Full Text] [Related]
17. Furin cleavage of the respiratory syncytial virus fusion protein is not a requirement for its transport to the surface of virus-infected cells.
Sugrue RJ; Brown C; Brown G; Aitken J; McL Rixon HW
J Gen Virol; 2001 Jun; 82(Pt 6):1375-1386. PubMed ID: 11369882
[TBL] [Abstract][Full Text] [Related]
18. Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection.
Yamazaki H; Tsutsumi H; Matsuda K; Nagai K; Ogra PL; Chiba S
J Gen Virol; 1994 Aug; 75 ( Pt 8)():2115-9. PubMed ID: 8046418
[TBL] [Abstract][Full Text] [Related]
19. Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons.
Falsey AR; Koval C; DeVincenzo JP; Walsh EE
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28054734
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.
Fries L; Shinde V; Stoddard JJ; Thomas DN; Kpamegan E; Lu H; Smith G; Hickman SP; Piedra P; Glenn GM
Immun Ageing; 2017; 14():8. PubMed ID: 28413427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
